TOPK: A new predictor of the therapeutic response to neoadjuvant chemotherapy and prognosis in triple-negative breast cancer

CONCLUSION: TOPK may be a novel predictor for the therapeutic response to NACT and prognosis for patients with TNBC.PMID:34500374 | DOI:10.1016/j.prp.2021.153603

Source: Pathology, Research and Practice - September 9, 2021 Category: Pathology Authors: Kaijing Wang Jia Chai Junpeng Xu Jie Wei Peifeng Li Yixiong Liu Jing Ma Tianqi Xu Danhui Zhao Kangjie Yu Linni Fan Qingguo Yan Shuangping Guo Mingyang Li Zhe Wang Source Type: research